Therapeutic Goods (Charges) Regulations (Amendment)

Overview

The Therapeutic Goods (Charges) Regulations (Amendment) 1991 No. 85, issued under the authority of the Minister of State for Aged, Family and Health Services, amends the Therapeutic Goods (Charges) Regulations 1990. The original Therapeutic Goods (Charges) Act 1989 was enacted to provide a legislative framework for imposing charges on various aspects of the regulation and administration of therapeutic goods in Australia. The primary objective of this Act is to ensure that the costs associated with the regulation of therapeutic goods are adequately covered by the fees and charges imposed on manufacturers and other stakeholders. The 1991 amendment aims to address any gaps or updates required in the charging structure, ensuring it remains fair and reflective of the economic realities faced by manufacturers, particularly smaller entities. By reducing the annual licence charge for manufacturers with a wholesale turnover of up to $50,000, the amendment seeks to support smaller businesses within the therapeutic goods industry, thereby promoting a balanced and supportive regulatory environment.

Scope and Application

The Therapeutic Goods (Charges) Regulations (Amendment) 1991 No. 85 applies to entities involved in the manufacture, supply, or importation of therapeutic goods in Australia. It extends to any person or entity that holds a licence under the Therapeutic Goods Act 1989 and is required to pay charges for the regulation of therapeutic goods. The application of these regulations is national, covering all states and territories within the Commonwealth of Australia. The amending Regulations specify that charges for licence holders with a wholesale turnover of not more than $50,000 will be reduced by 50%, providing a financial relief measure for small-scale manufacturers. The scope of the Act is further extended through subordinate instruments, which allow for the detailed specification of charges and conditions as necessitated by changes in the therapeutic goods market or regulatory requirements.

Key Provisions

The Therapeutic Goods (Charges) Regulations (Amendment) 1991 No. 85 amends the existing Therapeutic Goods (Charges) Regulations by introducing new provisions regarding charges for certain therapeutic goods licences. According to the amending Regulation 2.1, a significant change pertains to the annual charge for a licence. Specifically, this charge will be reduced to 50% for manufacturers whose wholesale turnover does not exceed $50,000, as outlined in regulation 45A of the Therapeutic Goods Regulations (Section 5). This amendment aims to provide a financial relief mechanism for smaller manufacturers who might otherwise face a higher financial burden. The amending Regulations impose specific obligations on the entities governed by the Act. For instance, manufacturers whose wholesale turnover does not exceed $50,000 must ensure that they meet the criteria specified in regulation 45A to be eligible for the reduced charge. Additionally, they must keep accurate records of their wholesale turnover to substantiate their eligibility for the reduced charge, as per the requirements outlined in the amending Regulation 2.1. Failure to comply with these obligations could result in the entity being ineligible for the reduced charge. Failure to adhere to the provisions set out in the amending Regulations could lead to various consequences. For instance, if a manufacturer incorrectly claims a reduced charge despite not meeting the specified turnover threshold, they could be subject to penalties. While the exact penalties are not detailed in the explanatory statement, the general nature of such breaches typically includes financial penalties and potential legal action to recover any improperly paid charges. The maximum penalties for such breaches, however, would need to be referred to in the Therapeutic Goods (Charges) Act 1989 or relevant regulations for a precise understanding.